| 1. |
DiFrancesco, D. (1995) The onset and autonomic regulation of cardiac pacemaker activity: Relevance of the f current. Cardiovasc Res.
29, 449–456.
|
| |
| 2. |
Yanagihara, K. and Irisawa, H. (1980) Inward current activated during hyperpolarization in the rabbit sinoatrial node cell.
Pflugers Arch.
385, 11–19.
|
| |
| 3. |
Brown, H. F., Giles, W., and Noble, S. J. (1977) Membrane currents underlying activity in frog sinus venosus. J. Physiol.
271, 783–816.
|
| |
| 4. |
DiFrancesco, D. (1981) A new interpretation of the pace-maker current in calf Purkinje fibres. J. Physiol.
314, 359–376.
|
| |
| 5. |
Brown, H. and DiFrancesco, D. (1980) Voltage-clamp investigations of membrane currents underlying pace-maker activity in rabbit
sino-atrial node. J. Physiol.
308, 331–351.
|
| |
| 6. |
DiFrancesco, D. and Ojeda, C. (1980) Properties of the current if in the sino-atrial node of the rabbit compared with those
of the current iK, in Purkinje fibres. J. Physiol.
308, 353–367.
|
| |
| 7. |
Irisawa, H. and Noma, A. (1984) Pacemaker currents in mammalian nodal cells. J. Mol. Cell Cardiol.
16, 777–781.
|
| |
| 8. |
Maylie, J. and Morad, M. (1984) Ionic currents responsible for the generation of pacemaker current in the rabbit sino-atrial
node. J. Physiol.
355, 215–235.
|
| |
| 9. |
Bader, C. R., Macleish, P. R., and Schwartz, E. A. (1979) A voltage-clamp study of the light response in solitary rods of
the tiger salamander. J. Physiol.
296, 1–26.
|
| |
| 10. |
DiFrancesco, D. (1993). Pacemaker mechanisms in cardiac tissue. Annu. Rev. Physiol.
55, 455–472.
|
| |
| 11. |
McCormick, D. A. and Pape, H. C. (1990) Properties of a hyperpolarization-activated cation current and its role in rhythmic
oscillation in thalamic relay neurones. J. Physiol.
431, 291–318.
|
| |
| 12. |
Pape, H. C. (1996) Queer current and pacemaker: The hyperpolarization-activated cation current in neurons. Annu. Rev. Physiol.
58, 299–327.
|
| |
| 13. |
Maccaferri, G. and McBain, C. J. (1996) The hyperpolarization-activated current (Ih) and its contribution to pacemaker activity
in rat CA1 hippocampal stratum oriens-alveus interneurones. J. Physiol.
497, 119–130.
|
| |
| 14. |
Luthi, A. and McCormick, D.A. (1998) H-current: Properties of a neuronal and network pacemaker. Neuron
21, 9–12.
|
| |
| 15. |
Demontis, G. C., Longoni, B., Barcaro, U., and Cervetto, L. (1999) Properties and functional roles of hyperpolarization-gated
currents in guinea-pig retinal rods. J. Physiol.
515, 813–828.
|
| |
| 16. |
Magee, J. C. (1999) Dendritic Ih normalizes temporal summation in hippocampal CA1 neurons. Nat. Neurosci.
2, 848.
|
| |
| 17. |
Beaumont, V. and Zucker, R. S. (2000) Enhancement of synaptic transmission by cyclic AMP modulation of presynaptic Ih channels.
Nat. Neurosci.
3, 133–141.
|
| |
| 18. |
Southan, A. P., Morris, N. P., Stephens, G. J., and Robertson, B. (2000) Hyperpolarization activated currents in presynaptic
terminals of mouse cerebellar basket cells. J. Physiol.
526, 91–97.
|
| |
| 19. |
DiFrancesco, D. (1995) The pacemaker current (I(f)) plays an important role in regulating SA node pacemaker activity. Cardiovasc. Res.
30, 307–308.
|
| |
| 20. |
Vassalle, M. (1995) The pacemaker current (I(f)) does not play an important role in regulating SA node pacemaker activity.
Cardiovasc. Res.
30, 309–310.
|
| |
| 21. |
Noble, D., Denyer, J. C., Brown, H. F., and DiFrancesco, D. (1992) Reciprocal role of the inward currents ib, Na and i(f)
in controlling and stabilizing pacemaker frequency of rabbit sino-atrial node cells. Proc. R Soc. Lond. B Biol. Sci.
250, 199–207.
|
| |
| 22. |
Liu, Y. M., Yu, H., Li, C. Z., Cohen, I. S., and Vassalle, M. (1998) Cesium effects on If and IK in rabbit sinoatrial node
myocytes. Implications for SA node automaticity. J. Cardiovasc. Pharmacol.
32, 783–790.
|
| |
| 23. |
Baker, K., Warren, K. S., Yellen, G., and Fishman, M. C. (1997) Defective “pacemaker” current (Ih) in a zebrafish mutant with
a slow heart rate. Proc. Natl. Acad. Sci. USA
94, 4554–4559.
|
| |
| 24. |
DiFrancesco, D., Ferroni, A., Mazzanti, M., and Tromba, C. (1986) Properties of the hyperpolarizing-activated current (if)
in cells isolated from the rabbit sino-atrial node. J. Physiol.
377, 61–68.
|
| |
| 25. |
DiFrancesco, D. (1986) Characterization of single pacemaker channels in cardiac sinoatrial node cells. Nature
324, 470–473.
|
| |
| 26. |
DiFrancesco, D. and Tortora, P. (1991) Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature
351, 145–147.
|
| |
| 27. |
DiFrancesco, D. and Mangoni, M. (1994) Modulation of single hyperpolarization-activated channels (i(f)) by cAMP in the rabbit
sino-atrial node. J. Physiol.
474, 473–482.
|
| |
| 28. |
Accili, E. A., Redaelli, G., and DiFrancesco, D. (1997) Differential control of the hyperpolarization-activated current (i(f))
by cAMP gating and phosphatase inhibition in rabbit sino-atrial node myocytes. J. Physiol.
500, 643–651.
|
| |
| 29. |
Chang, F., Cohen, I. S., DiFrancesco, D., Rosen, M. R., and Tromba, C. (1991) Effects of protein kinase inhibitors on canine
Purkinje fibre pacemaker depolarization and the pacemaker current i(f). J. Physiol.
440, 367–384.
|
| |
| 30. |
Wu, J. Y., Yu, H., and Cohen, I. S. (2000) Epidermal growth factor increases i(f) in rabbit SA node cells by activating a
tyrosine kinase. Biochim. Biophys. Acta.
1463, 1–19.
|
| |
| 31. |
Renaudon, B., Lenfant, J., Decressac, S., and Bois, P. (2000) Thyroid hormone increases the conductance density of f-channels
in rabbit sino-atrial node cells. Receptors Channels
7, 1–8.
|
| |
| 32. |
Hara, M., Liu, Y. M., Zhen, L., Cohen, I. S., Yu, H., Danilo P, Jr., et al. (1997) Positive chronotropic actions of parathyroid
hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker
potential. Circulation
96, 3704–3709.
|
| |
| 33. |
DiFrancesco, D. and Tromba, C. (1988) Inhibition of the hyperpolarization-activated current (if) induced by acetylcholine
in rabbit sino-atrial node myocytes. J. Physiol.
405, 477–491.
|
| |
| 34. |
Santoro, B. and Tibbs, G. R. (1999) The HCN gene family: Molecular basis of the hyperpolarization-activated pacemaker channels.
Ann. NY Acad. Sci.
868, 741–764.
|
| |
| 35. |
Yu, H., Chang, F., and Cohen, I. S. (1995) Pacemaker current If in adult canine cardiac ventricular myocytes. J. Physiol.
485, 469–483.
|
| |
| 36. |
Santoro, B., Grant, S. G., Bartsch, D., and Kandel, E. R. (1997) Interactive cloning with the SH3 domain of N-src identifies
a new brain specific ion channel protein, with homology to eag and cyclic nucleotide-gated channels. Proc. Natl. Acad. Sci. USA
94, 14,815–14,820.
|
| |
| 37. |
Ishii, T. M., Takano, M., Xie, L. H., Noma, A., and Ohmori, H. (1999) Molecular characterization of the hyperpolarization-activated
cation channel in rabbit heart sinoatrial node. J. Biol. Chem.
274, 12,835–12,839.
|
| |
| 38. |
Ludwig, A., Zong, X., Jeglitsch, M., Hofmann, F., and Biel, M. (1998) A family of hyperpolarization-activated mammalian cation
channels. Nature
393, 587–591.
|
| |
| 39. |
Santoro, B., Liu, D. T., Yao, H., Bartsch, D., Kandel, E. R., Siegelbaum, S. A., and Tibbs, G. R. (1998). Identification of
a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell
93, 717–729.
|
| |
| 40. |
Vaccari, T., Moroni, A., Rocchi, M., Gorza, L., Bianchi, M. E., Beltrame, M., and DiFrancesco, D. (1999) The human gene coding
for HCN2, the pacemaker channel of the heart. Biochim. Biophys. Acta.
1446, 419–425.
|
| |
| 41. |
Moroni, A., Barbuti, A., Altomare, C., Viscomi, C., Morgan, J., Baruscotti, M., and DiFrancesco, D. (2000) Kinetic and ionic
properties of the human HCN2 pacemaker channel. Pflügers Arch.
439, 618–626.
|
| |
| 42. |
Clapham, D. E. (1998) Not so funny anymore: Pacing channels are cloned. Neuron
21, 5–7.
|
| |
| 43. |
Biel, M., Ludwig, A., Zong, X., and Hofmann, F. (1999) Hyperpolarization-activated cation channels: A multi-gene family. Rev. Physiol. Biochem. Pharmacol.
136, 165–181.
|
| |
| 44. |
Vaca, L., Stieber, J., Zong, X., Ludwig, A., Hofmann, F., and Biel, M. (2000) Mutations in the S4 domain of a pacemaker channel
alter its voltage dependence. FEBS Lett.
479, 35–40.
|
| |
| 45. |
Doyle, D. A., Morais Cabral, J., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., et al. (1998) The structure of the
potassium channel: molecular basis of K+ conduction and selectivity. Science
280, 69–77.
|
| |
| 46. |
Heginbotham, L., Lu, Z., Abramson, T., and MacKinnon, R. (1994) Mutations in the K+ channel signature sequence. Biophys. J.
66, 1061–1067.
|
| |
| 47. |
Zagotta, W. N. and Siegelbaum, S. A. (1996) Structure and function of cyclic nucleotidegated channels. Annu. Rev. Neurosci.
19, 235–263.
|
| |
| 48. |
Wainger, B. J., DeGennaro, M., Santoro, B., Siegelbaum, S. A., and Tibbs, G. R. (2001) Molecular mechanism of cAMP modulation
of HCN pacemaker channels. Nature
411, 805–810.
|
| |
| 49. |
Ludwig, A., Zong, X., Stieber, J., Hullin, R., Hofmann, F., and Biel, M. (1999) Two pacemaker channels from human heart with
profoundly different activation kinetics. EMBO J.
18, 2323–2329.
|
| |
| 50. |
Santoro, B., Chen, S., Luthi, A., Pavlidis, P., Shumyatsky, G. P., Tibbs, G. R., et al. (2000) Molecular and functional heterogeneity
of hyperpolarization-activated pacemaker channels in the mouse CNS. J. Neurosci.
20, 5264–5275.
|
| |
| 51. |
Seifert, R., Scholten, A., Gauss, R., Mincheva, A., Lichter, P., and Kaupp, U. B. (1999) Molecular characterization of a slowly
gating human hyperpolarization-activated channel predominantly expressed in thalamus, heart, and testis. Proc. Natl. Acad. Sci. USA
96, 9391–9396.
|
| |
| 52. |
Yu, H., Wu, J., Potapova, I., Wymore, R. T., Holmes, B., Zuckerman, J., et al. (2001) MinK-related peptide 1: A beta subunit
for the HCN ion channel subunit family enhances expression and speeds activation. Circ. Res.
88, E847–E87.
|
| |
| 53. |
Maruoka, F., Nakashima, Y., Takano, M., Ono, K., and Noma, A. (1994) Cation-dependent gating of the hyperpolarization-activated
cation current in the rabbit sino-atrial node cells. J. Physiol.
477, 423–435.
|
| |
| 54. |
Solomon, J. S. and Nerbonne, J. M. (1993) Two kinetically distinct components of hyperpolarization-activated current in rat
superior colliculus-projecting neurons. J. Physiol.
469, 291–313.
|
| |
| 55. |
Chen, S., Wang, J., and Siegelbaum, S. A. (2001) Properties of hyperpolarization-activated pacemaker current defined by coassembly
of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide. J. Gen. Physiol.
117, 491–504.
|
| |
| 56. |
Boyett, M. R., Honjo, H., and Kodama, I. (2000) The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc. Res.
47, 658–687.
|
| |
| 57. |
Shi, W., Wymore, R., Yu, H., Wu, J., Wymore, R. T., Pan, Z., et al. (1999) Distribution and prevalence of hyperpolarization-activated
cation channel (HCN) mRNA expression in cardiac tissues. Circ. Res.
85, e1–e6.
|
| |
| 58. |
Zhang, H., Holden, A. V., and Boyett, M. R. (2000) Gradient model versus mosaic model of the sinoatrial node. Circulation
103, 584–588.
|
| |
| 59. |
Nikmaram, M. R., Boyett, M. R., Kodama, I., Suzuki, R., and Honjo, H. (1997) Variation in effects of Cs+, UL-FS-49, and ZD-7288 within sinoatrial node. Am. J. Physiol.
272, H2782–H2792.
|
| |
| 60. |
Moosmang, S., Stieber, J., Zong, X., Biel, M., Hofmann, F., and Ludwig, A. (2001) Cellular expression and functional characterization
of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur. J. Biochem.
268, 1646–1652.
|
| |
| 61. |
Monteggia, L. M., Eisch, A. J., Tang, M. D., Kaczmarek, L. K., and Nestler, E. J. (2000) Cloning and localization of the hyperpolarization-activated
cyclic nucleotide-gated channel family in rat brain. Brain Res. Mol. Brain Res.
81, 129–139.
|
| |
| 62. |
Greenwood, I. A. and Prestwich, S. A. (2002) Characteristics of hyperpolarization-activated cation currents in portal vein
smooth muscle cells. Am. J. Physiol. Cell Physiol.
282, C744–C753.
|
| |
| 63. |
Stevens, D. R., Seifert, R., Bufe, B., Muller, F., Kremmer, E., Gauss, R., et al. (2001) Hyperpolarization-activated channels
HCN1 and HCN4 mediate responses to sour stimuli. Nature
413, 631–635.
|
| |
| 64. |
Boudoulas, H., Rittgers, S., Lewis, R., Leier, C., and Weissler, A. (1979) Changes in diastolic time with various pharmacologic
agents: Implications for myocardial perfusion. Circulation
60, 164–169.
|
| |
| 65. |
Hoffman, J. (1990) Autoregulation and heart rate. Circulation
82, 1880–1881.
|
| |
| 66. |
Guth, B., Heusch, G., Seitelberger, R., and Ross, J. (1987) Elimination of exercise-induced regional myocardial dysfunction
by a bradycardic agent in dogs with chronic coronary stenosis. Circulation
75, 661–669.
|
| |
| 67. |
O’Brien, P., Drage, D., Saeian, K., Brooks, H., and Warltier, D. (1992) Regional redistribution of myocardial perfusion by
UL-FS49, a selective bradycardic agent. Am. Heart J.
123, 5665–5674.
|
| |
| 68. |
Schlack, W., Ebel, D., Grunert, S., Halilovic, S., Meyer, O., and Thamer, V. (1998) Effect of heart rate reduction by 4-(N-ethyl-N-phenyl-amino)-1,2-dimethyl-6-(methyl-amino)pyrimidinium
chloride on infarct size in dog. Arzneimittelforschung
48, 26–33.
|
| |
| 69. |
Indolfi, C., Guth, B. D., Miura, T., Miyazaki, S., Schulz, R., and Ross J. Jr. (1989) Mechanisms of improved ischemic regional
dysfunction by bradycardia. Studies on UL-FS 49 in swine. Circulation
80, 983–993.
|
| |
| 70. |
Cerbai, E., Sartiani, L., DePaoli, P., Pino, R., Maccherini, M., Bizzarri, F., et al. (2001) The properties of the pacemaker
current I(F)in human ventricular myocytes are modulated by cardiac disease. J. Mol. Cell Cardiol.
33, 441–448.
|
| |
| 71. |
Hoppe, U. C., Jansen, E., Sudkamp, M., and Beuckelmann, D. J. (1998) Hyperpolarization-activated inward current in ventricular
myocytes from normal and failing human hearts. Circulation
97, 55–65.
|
| |
| 72. |
DiFrancesco, D. (1982) Block and activation of the pace-maker channel in calf purkinje fibres: effects of potassium, caesium
and rubidium. J. Physiol.
329, 485–507.
|
| |
| 73. |
Zhou, Z. and Lipsius, S. L. (1992) Properties of the pacemaker current (If) in latent pacemaker cells isolated from cat right
atrium. J. Physiol.
453, 503–523.
|
| |
| 74. |
BoSmith, R. E., Briggs, I., and Sturgess, N. C. (1993) Inhibitory actions of ZENECA ZD7288 on whole-cell hyperpolarization
activated inward current (If) in guinea-pig dissociated sinoatrial node cells. Br. J. Pharmacol.
110, 343–349.
|
| |
| 75. |
Goethals, M., Raes A., and Van Bogaert, P. P. (1993) Use-dependent block of the pacemaker current I(f) in rabbit sinoatrial
node cells by zatebradine (UL-FS 49). On the mode of action of sinus node inhibitors. Circulation
88, 2389–2401.
|
| |
| 76. |
Traunecker, W. and Walland, A. (1980) Haemodynamic and electrophysiologic actions of alinidine in the dog. Arch. Int. Pharmacodyn. Ther.
244, 58–72.
|
| |
| 77. |
Harron, D. W., Jady, K., Riddell, J. G., and Shanks, R. G. (1982) Effects of alinidine, a novel bradycardic agent, on heart
rate and blood pressure in man. J. Cardiovasc. Pharmacol.
4, 213–220.
|
| |
| 78. |
Satoh, H. and Hashimoto, K. (1986) Electrophysiological study of alinidine in voltage clamped rabbit sino-atrial node cells.
Eur. J. Pharmacol.
121, 211–219.
|
| |
| 79. |
Millar, J. S. and Williams, E. M. (1981) Pacemaker selectivity: Influence on rabbit atria of ionic environment and of alinidine,
a possible anion antagonist. Cardiovasc. Res.
15, 335–350.
|
| |
| 80. |
Jaski, B. E. and Serruys, P. W. (1985) Anion-channel blockade with alinidine: A specific bradycardic drug for coronary heart
disease without negative inotropic activity? Am. J. Cardiol.
56, 270–275.
|
| |
| 81. |
McPherson, G. A. and Angus, J. A. (1989) Phentolamine and structurally related compounds selectively antagonize the vascular
actions of the K+ channel opener, cromromakalim. Br. J. Pharmacol.
97, 941–949.
|
| |
| 82. |
Streller, I. and Walland, A. (1990) Antiischemic effects of alinidine in paced isolated rat hearts. Basic Res Cardiol.
85, 71–77.
|
| |
| 83. |
Lang, U., Streller, I., and Walland, A. (1989) Alinidine antagonizes the myocardial effects of adenosine. Eur. J. Pharmacol.
164, 13–22.
|
| |
| 84. |
Lang, U. and Walland, A. (1989) Alinidine reverses the descending staircase of isolated rat atria by an antimuscarinic action.
Naunyn Schmiedebergs Arch. Pharmacol.
339, 456–463.
|
| |
| 85. |
Takeda, M., Furukawa, Y., Ogiwara, Y., Saegusa, K., Haniuda, M., Akahane, K., et al. (1989) Effects on atrio-ventricular conduction
of alinidine and falipamil injected into the AV node artery of the anesthetized dog. Arch. Int. Pharmacodyn Ther.
297, 39–48.
|
| |
| 86. |
Aidonidis, I., Brachmann, J., Rizos, I., Zacharoulis, A., Stavridis, I., Toutouzas, P., et al. (1995) Electropharmacology
of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent
coronary artery occlusion. Cardiovasc. Drugs Ther.
9, 555–563.
|
| |
| 87. |
Boucher, M., Chassaing, C., and Chapuy, E. (1995) Cardiac electrophysiologic effects of alinidine, a specific bradycardic
agent, in the conscious dog: Plasma concentration-response relations. J. Cardiovasc. Pharmacol.
25, 229–233.
|
| |
| 88. |
Meinertz, T., Kasper, W., and Jahnchen, E. (1987) Alinidine in heart patients: Electrophysiologic and antianginal actions.
Eur. Heart J.
8, 109–114.
|
| |
| 89. |
Koenig, W., Stauch, M., Sund, M., Wanjura, D., and Henze, E. (1990) Hemodynamic effects of alinidine (ST 567) at rest and
during exercise in patients with chronic congestive heart failure. Am. Heart J.
119, 1348–1354.
|
| |
| 90. |
Van de Werf, F., Janssens, L., Brzostek, T., Mortelmans, L., Wackers, F. J., Willems, G. M., et al. (1993) Short-term effects
of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute
myocardial infarction receiving thrombolytic therapy. J. Am. Coll. Cardiol.
22, 407–416.
|
| |
| 91. |
Challinor-Rogers, J. L., Rosenfeldt, F. L., Du, X. J., and McPherson, G. A. (1997) Antiischemic and antiarrhythmic activities
of some novel alinidine analogs in the rat heart. J. Cardiovasc. Pharmacol.
29, 499–507.
|
| |
| 92. |
Leitch, S. P., Sears, C. E., Brown, H. F., and Paterson, D. J. (1995) Effects of high potassium and the bradycardic agents
ZD7288 and cesium on heart rate of rabbits and guinea pigs. J. Cardiovasc. Pharmacol.
25, 300–306.
|
| |
| 93. |
BoSmith, R. E., Briggs, I., and Sturgess, N. C. (1993) Inhibitory actions of Zeneca ZD7288 on whole-cell hyperpolarization
activated inward current (If) in guinea-pig dissociated sinoatrial node cells. Br. J. Pharmacol.
110, 343–349.
|
| |
| 94. |
Rothberg, B. S., Shin, K. S., Phale, P. S., and Yellen, G. (2002) Voltage-controlled gating at the intracellular entrance
to a hyperpolarization-activated cation channel. J. Gen. Physiol.
119, 83–91.
|
| |
| 95. |
Berger, F., Borchard, U., Gelhaar, R., Hafner, D., and Weis, T. (1994) Effects of the bradycardic agent ZD 7288 on membrane
voltage and pacemaker current in sheep cardiac Purkinje fibres. Naunyn Schmiedebergs Arch Pharmacol.
350, 677–684.
|
| |
| 96. |
Briggs, I., BoSmith, R. E., and Heapy, C. G. (1994) Effects of Zeneca ZD7288 in comparison with alinidine and UL-FS 49 on
guinea pig sinoatrial node and ventricular action potentials. J. Cardiovasc. Pharmacol.
24, 380–387.
|
| |
| 97. |
Harris, N. C. and Constanti, A. (1995) Mechanism of block by ZD 7288 of the hyperpolarization-activated inward rectifying
current in guinea pig substantia nigra neurons in vitro. J. Neurophysiol.
7, 2366–2378.
|
| |
| 98. |
Gasparini, S. and DiFrancesco, D. (1997) Action of the hyperpolarization-activated current (Ih) blocker ZD 7288 in hippocampal
CA1 neurons. Pflugers Arch.
435, 99–106.
|
| |
| 99. |
Satoh, T. O. and Yamada, M. (2000) A bradycardiac agent ZD7288 blocks the hyperpolarization-activated current (I(h)) in retinal
rod photoreceptors. Neuropharmacology
39, 1289–1291.
|
| |
| 100. |
Hohnloser, S., Weirich, J., Homburger, H., and Antoni, H. (1982) Electrophysiological studies on effects of AQ-A 39 in the
isolated guinea pig heart and myocardial preparations. Arzneimittelforschung
32, 730–734.
|
| |
| 101. |
Senges, J., Rizos, I., Brachmann, J., Anders, G., Jauernig, R., Hamman, H. D., et al. (1983) Effect of nifedipine and AQ-A
39 on the sinoatrial and atrioventricular nodes of the rabbit and their antiarrhythmic action on atrioventricular nodal reentrant
tachycardia. Cardiovasc. Res.
17, 132–134.
|
| |
| 102. |
Kawada, M., Satoh, K., and Taira, N. (1984) Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated,
blood-perfused dog-heart preparations. J. Pharmacol. Exp. Ther.
228, 484–490.
|
| |
| 103. |
Dammgen, J., Kadatz, R., and Diederen, W. (1981) Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino]
propyl) phthalimidine (AQ-A 39), a specific bradycardic agent. Arzneimittelforschung
31, 666–670.
|
| |
| 104. |
Verdouw, P. D., Bom, H. P., and Bijleveld, R. E. (1983) Cardiovascular responses to increasing plasma concentrations of AQ-A
39 Cl, a new compound with negative chronotropic effects. Arzneimittelforschung
33, 702–706.
|
| |
| 105. |
Hilaire, J., Broustet, J. P., Colle, J. P., and Theron, M. (1983) Cardiovascular effects of AQ-A 39 in healthy volunteers.
Br. J. Clin. Pharmacol.
16, 627–631.
|
| |
| 106. |
Siegl, P. K., Wenger, H. C., and Sweet, C. S. (1984) Comparison of cardiovascular responses to the bradycardic drugs, alinidine,
AQ-A 39, and mixidine, in the anesthetized dog. J. Cardiovasc. Pharmacol.
6, 565–574.
|
| |
| 107. |
Gross, G. J., Daemmgen, J. W. (1986) Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208
on reversible myocardial reperfusion damage in anesthetized dogs. J. Pharmacol. Exp. Ther.
238, 422–428.
|
| |
| 108. |
Gilfrich, H. J., Oberhoffer, M., and Witzke, J. (1987) Comparison of AQ-A 39 with propanolol and placebo in ischaemic heart
disease. Eur. Heart J.
8(Suppl L), 147–151.
|
| |
| 109. |
Roth, W., Koss, F. W., Hallinan, D., Lambe, R., and Darragh, A. (1990) Pharmacokinetics of falipamil after intravenous administration
to humans. J. Pharm. Sci.
79, 415–419.
|
| |
| 110. |
Osterrieder, W., Pelzer, D., Yang, Q. F., and Trautwein, W. (1981) The electrophysiological basis of the bradycardic action
of AQA 39 on the sinoatrial node. Naunyn Schmiedebergs Arch Pharmacol.
317, 233–237.
|
| |
| 111. |
Boucher, M., Chassaing, C., Chapuy, E., and Duchene-Marullaz, P. (1994) Chronotropic cardiac effects of falipamil in conscious
dogs: Interactions with the autonomic nervous system and various ionic conductances. J. Cardiovasc. Pharmacol.
23, 569–575.
|
| |
| 112. |
Lillie, C. and Kobinger, W. (1986) Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxy-phenyl)ethyl]methyl-imino]propyl]-2H-3-benzazepin-2-on
hydrochloride) in isolated guinea pig atria. J. Cardiovasc. Pharmacol.
8, 791–797.
|
| |
| 113. |
Johnston, W., Vinten-Johansen, J., Tommasi, E., and Little, W. (1991) ULFS-49 causes bradycardia without decreasing right
ventricular systolic and diastolic performance. J. Cardiovasc. Pharmacol.
18, 528–534.
|
| |
| 114. |
Chen, Z. and Slinker, B. (1992) The sinus node inhibitor UL-FS 49 lacks significant inotropic effect. J. Cardiovasc. Pharmacol.
19, 264–271.
|
| |
| 115. |
Van Woerkens, L., van der Giessen, W., and Verdouw, P. (1992) The selective bradycardic effects of zatebradine (UL-FS 49)
do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion. Cardiovasc. Drugs Ther.
6, 59–65.
|
| |
| 116. |
Breall, J., Watanabe, J., and Grossman, W. (1993) Effect of zatebradine on contractility, relaxation and coronary blood flow.
J. Am. Coll. Cardiol.
21, 471–477.
|
| |
| 117. |
Pistchner, H., Muno, E., Vens-Cappel, F., Schulte, B., Schlepper, M., de Moura-Sieber, V., et al. Antiischemic, antianginal,
and hemodynamic effects of ULFS 49 Cl (a new heart-rate-reducing agent) in patients with angiographically proven CAD, in Sinus Node Inhibitors: A New Concept in Angina Pectoris (Hjalmarson, Å., Remme, W., eds.), Springer, New York, 1991, pp. 45–53.
|
| |
| 118. |
Baiker, W., Czako, E., Keck, M., and Nehmiz, G. Efficacy and duration of action of three doses of zatebradine (ULFS 49 Cl)
in patients with chronic angina pectoris compared to placebo, in Sinus Node Inhibitors: A New Concept in Angina Pectoris (Hjalmarson, Å., Remme, W., eds.), Springer, New York, 1991, pp. 55–63.
|
| |
| 119. |
Franke, H., Su CAPF, Schumacher, K., and Seiberling, M. (1987) Clinical pharmacology of two specific bradycardic agents. Eur. Heart J.
8(Suppl L), 91–98.
|
| |
| 120. |
Roth, W., Bauer, E., Heinzel, G., Cornelissen, P., van Tol, R., Jonkman, J., and Zuiderwijk, P. (1993) Zatebradine: pharmacokinetics
of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects. J. Pharm. Sci.
82, 99–106.
|
| |
| 121. |
Kobinger, W. and Lillie, C. (1984) Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl]
methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new “specific bradycardic agent”. Eur. J. Pharmacol.
104, 9–18.
|
| |
| 122. |
Van Bogaert, P. P., Goethals, M., and Simoens, C. (1990) Use-and frequency-dependent blockade by UL-FS 49 of the if pacemaker
current in sheep cardiac Purkinje fibres. Eur. J. Pharmacol.
187, 241–256.
|
| |
| 123. |
DiFrancesco, D. (1994) Some properties of the UL-FS 49 block of the hyperpolarization-activated current (i(f)) in sino-atrial
node myocytes. Pflugers Arch.
427, 64–70.
|
| |
| 124. |
Doerr, T. and Trautwein, W. (1990) On the mechanism of the “specific bradycardic action” of the verapamil derivative UL-FS
49. Naunyn Schmiedebergs Arch Pharmacol.
341, 331–340.
|
| |
| 125. |
Thollon, C., Cambarrat, C., Vian, J., Prost, J. F., Peglion, J. L., and Vilaine, J. P. (1994) Electrophysiological effects
of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: Comparison with UL-FS 49. Br. J. Pharmacol.
112, 37–42.
|
| |
| 126. |
Perez, O., Gay, P., Franqueza, L., Carron, R., Valenzuela, C., Delpon, E., et al. (1995) Electromechanical effects of zatebradine
on isolated guinea pig cardiac preparations. J. Cardiovasc. Pharmacol.
26, 46–54.
|
| |
| 127. |
Raberger, G., Krumpl, G., and Schneider, W. (1987) Effects of the bradycardic agent UL-FS 49 on exercise-induced regional
contractile dysfunction in dogs. Int. J. Cardiol.
14, 343–354.
|
| |
| 128. |
Frishman, W. H., Pepine, C. J., Weiss, R. J., and Baiker, W. M. (1995) Addition of zatebradine, a direct sinus node inhibitor,
provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: Results of a multicenter,
randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group. J. Am. Coll. Cardiol.
26, 305–312.
|
| |
| 129. |
Glasser, S. P., Michie, D. D., Thadani, U., and Baiker, W. M. (1997) Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor,
on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators. Am. J. Cardiol.
79, 1401–1405.
|
| |
| 130. |
Valenzuela, C., Delpon, E., Franqueza, L., Gay, P., Perez, O., Tamargo, J., and Snyders, D. J. (1996) Class III antiarrhythmic
effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation
94, 562–570.
|
| |
| 131. |
Bois, P., Bescond, J., Renaudon, B., and Lenfant, J. (1996) Mode of action of bradycardic agent, S 16257, on ionic currents
of rabbit sinoatrial node cells. Br. J. Pharmacol.
118, 1051–1057.
|
| |
| 132. |
Thollon, C., Bidouard, J. P., Cambarrat, C., Lesage, L., Reure, H., Delescluse, I., et al. (1997) Stereospecific in vitro
and in vivo effects of the new sinus node inhibitor (+)-S 16257. Eur. J. Pharmacol.
339, 43–51.
|
| |
| 133. |
Simon, L., Ghaleh, B., Puybasset, L., Giudicelli, J. F., and Berdeaux, A. (1995) Coronary and hemodynamic effects of S 16257,
a new bradycardic agent, in resting and exercising conscious dogs. J. Pharmacol. Exp. Ther.
275, 659–666.
|
| |
| 134. |
Monnet, X., Ghaleh, B., Colin, P., de Curzon, O. P., Giudicelli, J. F., and Berdeaux, A. (2001) Effects of heart rate reduction
with ivabradine on exercise-induced myocardial ischemia and stunning. J. Pharmacol. Exp. Ther.
299, 1133–1139.
|
| |
| 135. |
Carre, F., Denolle, T., Lecoz, F., Violet, I., Lerebours, G., and Gandon, J. M. (1995). First intravenous phase I of S 16257,
a new bradycardic agent: Effects on the maximal exercise parameters. Thérapie
50, 377.
|
| |
| 136. |
Duffull, S. B., Chabaud, S., Nony, P., Laveille, C., Girard, P., and Aarons, L. (2000) A pharmacokinetic simulation model
for ivabradine in healthy volunteers. Eur. J. Pharm. Sci.
10, 285–294.
|
| |
| 137. |
Maesen, F. P., Smeets, J. J., van Noord, J. A., Nehmiz, G., Wald, F. D., and Cornelissen, P. J. (1994) Effect of zatebradine,
a novel’ sinus node inhibitor,’ on pulmonary function compared to placebo. Pulm. Pharmacol.
7, 349–355.
|
| |